HIM
DRTSW icon

HGC Investment Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

HGC Investment Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,296
Closed -$1.2K – 81
2024
Q3 		$1.2K Hold
6,296
– – ﹤0.01% 94
2024
Q2 		$1.27K Hold
6,296
– – ﹤0.01% 90
2024
Q1 		$1.57K Hold
6,296
– – ﹤0.01% 80
2023
Q4 		$1.21K Buy
+6,296
New +$1.52K ﹤0.01% 80
2023
Q1 		– Sell
-256,395
Closed -$64K – 233
2022
Q4 		$64K Sell
256,395
-317,326
-55% -$97.1K 0.01% 233
2022
Q3 		$256K Buy
+573,721
New +$338K 0.02% 257

Other funds holding DRTSW

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HGC Investment Management's DRTSW Position: Q4 2024 in Review

HGC Investment Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2024, closing a stake of 6,296 shares — an estimated $1.2K sold.

HGC Investment Management first reported a position in DRTSW in Q3 2022 and held it in 6 quarters. The position peaked at $256K in Q3 2022. 26 funds tracked by Wall St. Rank hold DRTSW as of Q4 2024.

  • HGC Investment Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2024 after selling out during the quarter.
  • HGC Investment Management sold 6,296 Alpha Tau Medical Warrant shares in Q4 2024, an estimated $1.2K.
  • HGC Investment Management first reported a position in Alpha Tau Medical Warrant in Q3 2022 and held it in 6 quarters.
  • HGC Investment Management's Alpha Tau Medical Warrant position peaked at $256K in Q3 2022.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2024.

Based on HGC Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.